Status:
RECRUITING
A National Registry on Chinese Patients With Cystic Fibrosis
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Pulmonary Function
Eligibility:
All Genders
Brief Summary
Cystic fibrosis (CF) is a rare autosomal recessive disease involving multiple organs, especially the lungs and digestive organs. It is most commonly seen in Caucasians. Only a few Chinese CF patients ...
Eligibility Criteria
Inclusion
- Fulfilled WHO clinical diagnostic criteria for CF; Was in a stable phase with no respiratory infections for nearly 4 weeks; Subjects (or their guardians) signed informed consent.
Exclusion
- Patients with other bronchiectasis who did not meet the inclusion criteria; Those with severe cardiac or renal disease
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2032
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05289245
Start Date
April 1 2022
End Date
October 1 2032
Last Update
March 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China